Hepatic Impairment Study for Lorlatinib in Cancer Patients
Clinical trial NCT03726333 · TERMINATED
Trial details
- NCT number
- NCT03726333
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-14
- Primary completion
- 2021-07-08
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.